Nektar Therapeutics
Nektar Therapeutics
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis | Moderate-to-Severe Atopic Dermatitis | Recruiting | Phase 3 | 2026-09-14 | NCT07690371 | |
| A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis | Moderate-to-Severe Atopic Dermatitis | Recruiting | Phase 3 | 2026-09-08 | NCT07711418 | |
| A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis | Moderate to Severe Atopic Dermatitis | Active, not recruiting | Phase 2 | 2026-08-21 | NCT06136741 | |
| REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE) | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-07-29 | NCT05632809 |